Dermatology Diagnostic Device Market Share

Global Dermatology Diagnostic Devices Market Overview

Dermatology Diagnostic device Market Size was valued at USD 7.10 Billion in 2023. The Dermatology Diagnostic device industry is projected to grow from USD 7.48 Billion in 2024 to USD 13.23 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 12.21% during the forecast period (2024 - 2032). The term dermatology means the medical field related to the treatment and diagnosis of skin diseases. The diagnosis is done through microscopic and visual examination. Furthermore, the diagnosis devices are majorly used that enhance the treatment.

Several factors such as the rising condition of skin diseases are promoting the lucrative growth of the Dermatology Diagnostic Devices. It is evaluated that North America will have the largest share. However, the Asia-Pacific region is anticipated to record the fastest growth in the studied forecast period.

COVID-19 Analysis

The coronavirus disease halted the development and growth of the Dermatology Diagnostic Devices Market. It caused the shutdown of various businesses across the world for several months. This has caused the online shift and boosted the market growth significantly. This factor however emerged as a growth factor. However, the resumption of market opening and developments by market players will further improve the market growth.

In August 2023, Perfect Corp., a prominent provider of artificial intelligence (AI) and augmented reality (AR) beauty and fashion technology solutions, revealed a collaboration with ELEMIS to introduce a cutting-edge skin diagnostic experience for the worldwide British skincare brand. The ELEMIS AI Skin Experience utilizes Perfect Corp.'s acclaimed AI Skin Diagnostic technology to offer consumers a comprehensive skin evaluation. It then recommends the most suitable skincare product routine tailored to their individual requirements. The AI Skin tool will be exclusively available on mobile devices and will initially launch on elemis.com in the UK and US. There are future plans to increase its availability worldwide in the upcoming months. Customers frequently have a sense of being inundated by the multitude of skincare choices at their disposal. Perfect Corp. effectively addresses this issue by swiftly and effortlessly guiding them towards the appropriate skincare routine that caters to their individual requirements. Initially, consumers are required to fill out a questionnaire in order to furnish details regarding their primary skin concerns and objectives, as well as their preferences for product formulas. Following that, the consumer undergoes a comprehensive skin scan utilizing Perfect Corp.'s cutting-edge AI technology.

In June 2023, the company utilizes its exclusive technology and comprehensive database to employ 3D imaging and consumer health data for the purpose of analyzing the user's skin and hair characteristics. This analysis is then used to identify the most suitable solutions for addressing specific hair and skin care concerns, such as dryness and sensitivity. In the past year, Skin Dossier, a technology startup, introduced its exclusive Software as a Service (SAAS) platform featuring an interactive database designed for evaluating consumer skin. The company's "Precision Skin Health Advisor" technology provides consumers with a six-minute skin care assessment. This assessment includes a Lifestyle Quiz and 3D Facial Imaging using a smartphone. The technology then syncs the consumer's geolocation, health app, DNA data, and optional blood test data. Based on this information, users receive their Skin Dossier Report and Recommendations. The technology evaluates more than 300 skin characteristics and cross-references more than one million images in its database, along with over 2,500 genomics studies, over 500,000 distinct profiles in its exclusive Population DNA + Phenotype database, and over 4,000 research publications. This assessment is used to determine the user's skin and hair profile and find the most suitable products from a selection of 10,000 SKUs to address their specific concerns.

Dermatology Diagnostic Devices Market Trends

Market Drivers

The increasing technological advancements and increasing cases of skin cancer are the significant drivers. Also, the rising need for diagnostic devices and other growing awareness will further drive the Dermatology Diagnostic Devices Market Growth.

Restraints

The strict regulation policies among various countries can cause slow manufacturing of the products. That’s why this reason is anticipated to restraint the market growth in the future years.

Opportunities

Countries in Asia-Pacific especially India China are anticipated to offer new opportunities. The low labor costs and rising adoption of new technologies will further improve the chances of opportunities for Dermatology Diagnostic Devices Market Growth.

Challenges

Some challenges such as shortage of skilled labor and low awareness for new devices can be challenging for the market in the forthcoming years.

Cumulative Analysis

The Compound Annual Growth Rate (CAGR) of the Dermatology Diagnostic Devices Market is estimated to reach up to 19.7%. It is anticipated that the market value will further improve in the forthcoming years. Therefore, it will expand up to USD 6.5 Billion in the studied forecast period 2021-2028.

Value Chain Analysis

The improvement in the Dermatology Diagnostic Devices Market Tends due to increasing cases of skin diseases mainly skin cancer will have a significant impact on the market growth. Various factors such as improvement in the supply chain and growing development by the key players will eventually enhance the value chain of the market.

Dermatology Diagnostic Devices Market Segment Insights

The segments of the Dermatology Diagnostic Devices Market are divided into application, diagnostic devices, and end-users. Based on application, the market is divided into Dermatitis, Psoriasis, Skin Cancer, Lesion, Cellulitis, and Others. The skin cancer sub-segment is anticipated to lead the market in the upcoming years.

Based on diagnostic devices the Market is divided into Biopsy Devices, Microscopes, Dermatoscopes, and others. It is estimated that the dermatoscopic sub-segment will have lucrative growth in the future years. The rising cases of skin-cancer-related diseases are the crucial reason for this segment.

Based on end-users the Dermatology Diagnostic Devices Market is divided into Dermatology Clinics, Hospitals, and others. The Market Analysis suggests that dermatology clinic sub-segment will significantly in the future years.

Regional Analysis

The Dermatology Diagnostic Devices Market Size based on region is divided into Europe, North America, Asia-Pacific, and the Rest of the World. According to the Dermatology Diagnostic Devices Market Forecast, it is anticipated that the North American region will lead the market with the highest share. The major drivers of this region are the increasing cases of skin cancer and other types of skin diseases such as basal cell carcinoma. Also, the high adoption rate of new technologies and devices for treatment will further improve the market growth.

Furthermore, the European region is evaluated to have the second-largest Dermatology Diagnostic Devices Market Share. The growing emphasis by governments by introducing new policies and investments is the crucial reason for a significant share.

Moreover, the Asia-Pacific region is evaluated to have the fastest growth in the studied forecast period. The significant development in technology and other various aspects in countries such as India and China are fuelling the growth.

After that Rest of the World consists of regions of Latin America, Africa, and the Middle East. The segment of the rest of the world consists of regions of Latin America, Africa, and the Middle East. It is anticipated that the Dermatology Diagnostic Devices Market in this region will boost in the forthcoming years.

Competitive Landscape

The key players are playing a crucial role to improve the Dermatology Diagnostic Devices Market Growth. They do various mergers, partnerships, acquisitions, new ventures, etc. Some of the key players of the Dermatology Diagnostic Devices Market are listed below.

• Cynosure Inc. (US)


• Valeant Pharmaceuticals (Canada)


• V. Genentech Inc. (US)


• Alma Lasers Ltd. (Israel)


• Galderma S.A. (Switzerland)


• Cutera Inc. (US)


• Michelson Diagnostics Ltd. (UK)


• Lumenis Ltd. (Israel)


• Candela Corporation (US)


• 3Derm Systems Inc.(US)


• Ambicare Health (US)


• Solta Medical Inc. (US)


• Syneron Medical Ltd. (Israel)

Recent Developments

• 3Derm Systems Inc. in 2020 announces the approval by the FDA for its product called 3DermSpot. This is an algorithm equipped with artificial intelligence and skin images that helps to detect cancer diseases.


• Lancer Skincare in 2020 launched its first device for skin exfoliation called “Polish Microdermabrasion Device.”

Report Overview

The report overview of the Dermatology Diagnostic Devices Market Outlook is as follows.

• Market Overview


• COVID-19 Analysis


• Dynamics of the Market


• Value Chain Analysis


• Market Segmentation


• Regional Analysis


• Competitive Analysis


• Recent Development

Report Score and Segmentation

The report score is to provide valuable information about Dermatology Diagnostic Devices Market Forecast. This report highlights the information regarding CAGR, market value, challenges, recent developments, and many more. The information provided in this report is collected from various secondary and primary sources.

• Study Period- 2021-2028


• Base Year-2021


• Forecast Period- 2021-2028


• Historical Period-2017-2020

Dermatology Diagnostic Devices Market Segmentation

Dermatology Diagnostic Devices Diagnostic Devices Outlook

• Biopsy Devices


• Microscopes


• Dermatoscopes


• Others

Dermatology Diagnostic Devices Application Outlook

• Dermatitis


• Psoriasis


• Skin Cancer


• Lesion


• Cellulitis


• Others

Dermatology Diagnostic Devices End-Users Outlook

• Dermatology Clinics


• Hospitals


• Others

Dermatology Diagnostic Devices Regional Outlook

• Europe


• North America


• Asia-Pacific


• The Rest of the World